Company Active LTD

Company profile

Lucid Group Limited

Lucid Group - Intelligent connected medical device design

Lucid Group Limited is a UK company with status active founded in 2002.

CRN
04533078
Founded
2002
Age
23

Overview

Legal name
LUCID GROUP LIMITED
Region
Unknown
Registered address
UNIT 3 ENTERPRISE HOUSE
MANCHESTER SCIENCE PARK
MANCHESTER
ENGLAND
M15 6SE
Insolvency history
No

Corporate ownership

Updated 06 Jun 2026 16:52

Lucid Group Limited
No active corporate controller recorded.

Latest accounts

Financial period: 1 Apr 2024 to 31 Mar 2025

FILLETEDACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
11

Company events

Reference milestones and recent Companies House filing stream events.

7 events
31 Dec
2026

Accounts due

Accounts Due

Next accounts due date

11 Sep
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

28 Aug
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Mar
2025

Accounts filed

Accounts

Last accounts made up date

04 Sep
2024

Confirmation Statement With Updates

Confirmation-statement

CS01 | Transaction MzQzNDQ2MTQxOGFkaXF6a2N4

Published 04 Sep 2024 08:49

04 Sep
2024

Change Person Director Company With Change Date

Officers

CH01 | Transaction MzQzNDQ2MTQxNWFkaXF6a2N4

Published 04 Sep 2024 08:49

12 Sep
2002

Incorporated

Inception

Company registered at Companies House

Public funding

7 awards
First funded
2014
Funded years
2014, 2018, 2020, 2021, 2023
Age at first award
11 years

Projects

2023 Collaborative R&D Lead participant

BBconnect - a people-centred, system aware design feasibility investigation that aims to define innovation opportunities, generate and evaluate viable ideas for more accessible, effective and integrated bladder and bowel healthcare services.

1 Oct 2023 to 31 Mar 2024

Awarded
£43,548
Total cost £43,548

BBconnect is a people-centred, system aware design feasibility investigation. We aim to define innovation opportunities, generate and evaluate viable ideas for more accessible, effective and integrated bladder and bowel care services. Clinician-led charity Bladder and Bowel UK and design specialists Lucid Group will collaborate in discovery, co-design and...

2021 Collaborative R&D

Biostrain - development of a novel medical device for measuring and stabilising core-muscle imbalances, from lumbar-patients to elite-athletes.

1 May 2021 to 31 Jul 2023

Awarded
£400,631
Total cost £572,330

**Public description** Our experienced and proven team is developing Biostrain, a novel medical device to enable clinicians and users to diagnose and treat imbalances in muscle groups known to cause lower-back pain, spinal and hamstring injuries. This groundbreaking new technology will offer major advantages over current techniques, from a wide variety of...

2020 Collaborative R&D Lead participant

Content - a system to help dementia patients, carers and clinicians collaborate in reducing bladder and bowel incontinence , delivering carbon-footprint and cost reduction, physical and mental health benefits.

1 Dec 2020 to 31 Mar 2021

Awarded
£108,479
Total cost £135,599

The Content project aims to investigate the feasibility of helping dementia patients, carers and clinicians collaborate in prolonging bladder and bowel continence. Deliverables include investigation of a connected medical-device system that enables carbon-footprint, landfill, greenhouse-gas and cost-of-care reductions, delivering economic physical and men...

2020 Collaborative R&D Lead participant

Armie - a system for professionally supported “stay-at-home” cosmetic facial rejuvination therapies

1 Nov 2020 to 30 Apr 2021

Awarded
£99,389
Total cost £99,389

Armie is the development of a new business-model and device-prototype to address negative Covid-19 impacts on cosmetic treatment-services. The project will investigate potential for carbon-footprint reduction, from reduced travel and space requirements along-side a scalable business model with scope for world-wide franchise licensing.

2020 Collaborative R&D Lead participant

Zero - a connected device and service to accelerate child and adolescent bladder continence - reducing the environmental impacts of incontinence

1 Oct 2020 to 30 Jun 2021

Awarded
£151,094
Total cost £188,868

The Zero project aims to demonstrate the opportunity to deliver effective. connected and self-care remotely, addressing negative COVID-19 impacts on continence services facing restrictions provide the face-to-face advice and training to help young-people and carers. Resultant acceleration of developmental and disability related bladder-continence could de...

2018 Collaborative R&D Lead participant

An-i-sys Biofeedback - visual led therapy for faecal incontinence

1 Jan 2018 to 31 Mar 2020

Awarded
£726,363
Total cost £1,037,662

Luicd is developing a portable biofeedback therapy system, to enable a more accessible, joined-up diagnostic and therapuetic care pathway for patients with defecatory disorders. The innovation will enhance the capability and capacity of nurse led community continence services and help provide better information for referral to specialist care.

2014 Vouchers Lead participant

Innovation Voucher - LED total internal reflection

1 Feb 2014 to 31 Jul 2014

Awarded
£5,000
Total cost £5,000

The company is developing an ultra-low energy, light-weight light-source and needs specialist facilities, software and know-how to evaluate LED light output from prototypes and from existing "control" products

Product types

Collaborative R&D Vouchers